H. Shuto et al., ENHANCEMENT OF SEROTONERGIC NEURAL ACTIVITY CONTRIBUTES TO CYCLOSPORINE-INDUCED TREMORS IN MICE, European journal of pharmacology, 341(1), 1998, pp. 33-37
A single cyclosporine injection (50 mg/kg, i.p.) significantly enhance
d harmine but not oxotremorine-induced tremors in mice. This potentiat
ion became more apparent when cyclosporine (50 mg/kg, i.p.) was admini
stered once a day for seven days. These findings suggest an involvemen
t of monoaminergic mechanisms in cyclosporine-induced tremors. The eff
ects of cyclosporine were examined on the dynamics of noradrenaline, d
opamine and serotonin in the mouse brain. Both single and repeated tre
atment with cyclosporine significantly facilitated the serotonin turno
ver as estimated from the probenecid-induced accumulation of 5-hydroxy
indoleacetic acid, but either mode of treatment failed to change the c
ontents of monoamines and their metabolites or the turnover of noradre
naline and dopamine. Therefore thr cyclosporine-enhanced activity of s
erotonin neurons may be interpreted as producing adverse central effec
ts, including tremors. (C) 1998 Elsevier Science B.V.